
Novel ингибитор of glioblastoma multiforme (GBM), inhibiting клетка viability of low-passage patient-derived GBM spheroids, blocking tube-formation of endothelial cells in Matrigel, showing no effect on primary hematopoietic CD34+ progenitor spheroids or as
Novel inhibitor of glioblastoma multiforme (GBM), inhibiting cell viability of low-passage patient-derived GBM spheroids, blocking tube-formation of endothelial cells in Matrigel, showing no effect on primary hematopoietic CD34+ progenitor spheroids or as
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.